An Introduction to Testing for Drugs of Abuse. William E. Schreiber

An Introduction to Testing for Drugs of Abuse - William E. Schreiber


Скачать книгу
II – metabolites from phase I, or in some cases the unchanged drug, are conjugated to a water‐soluble group. This usually involves the addition of glucuronic acid or sulfate to an available –OH on the drug molecule (Figure 2.1). The reactions are catalyzed by UDP glucuronosyltransferase and sulfotransferase enzymes, respectively.

      The rate of metabolism varies among individuals. Genetic polymorphisms in CYP and other drug‐metabolizing enzymes affect their activity and can accelerate or slow down the rate of drug transformation. People who are slow metabolizers may experience toxicity from a drug at doses considered therapeutic. Conversely, rapid metabolizers require more drug to reach therapeutic levels in blood.

      Drugs and their metabolites are primarily excreted by two routes: (i) glomerular filtration into urine and (ii) transport into bile.

      The kidneys remove most drugs and their metabolites from the body. The pH of the glomerular filtrate affects the excretion of weakly acidic and basic drugs, because ionized molecules are not reabsorbed by renal tubules. Molecules that are smaller and more water soluble are usually excreted in this way.

      Biliary excretion requires active transport of drugs and metabolites out of liver cells and into the biliary system. Bile flows into the duodenum, and its contents are ultimately discharged in feces. Drugs that are larger (molecular weight [MW] >300) and more lipophilic are preferentially excreted in bile.

      Other routes of excretion exist but are less important. Volatile compounds can diffuse out of capillaries in the alveolar wall and enter the air spaces of the lungs, from which they are exhaled (e.g., ethanol). Excretion of drugs in breast milk may affect infants who are breastfeeding.

      Disease of the kidneys or liver can impair excretion, causing drug levels in blood and other body fluids to rise.

      Book chapter

      1 Correia, M.A. (2012). Drug biotransformation. In: Basic and Clinical Pharmacology, 12e (eds. B.G. Katzung, S.B. Masters and A.J. Trevor), 53–68. New York: McGraw‐Hill.

      Websites

      Pharmacology Education Project

        www.pharmacologyeducation.org/clinical‐pharmacology/clinical‐pharmacokinetics

      MSD Manual

      Drug Absorption

        www.msdmanuals.com/professional/clinical‐pharmacology/pharmacokinetics/drug‐absorption

      Drug Bioavailability

        www.msdmanuals.com/professional/clinical‐pharmacology/pharmacokinetics/drug‐bioavailability

      Drug Distribution to Tissues

        www.msdmanuals.com/professional/clinical‐pharmacology/pharmacokinetics/drug‐distribution‐to‐tissues

      Drug Metabolism

        www.msdmanuals.com/professional/clinical‐pharmacology/pharmacokinetics/drug‐metabolism

      Drug Excretion

        www.msdmanuals.com/professional/clinical‐pharmacology/pharmacokinetics/drug‐excretion

      Videos

      Pharmacokinetics 1 – Introduction

        www.youtube.com/watch?v=8‐Qtd6RhfVA

      Pharmacokinetics 2 – Absorption

        www.youtube.com/watch?v=pWW‐aq7iSa0

      Pharmacokinetics 3 – Distribution

        www.youtube.com/watch?v=6erefsWCVxg

      Pharmacokinetics 4 – Metabolism

        www.youtube.com/watch?v=ztsBn8gsfHw

      Pharmacokinetics 5 – Excretion

        www.youtube.com/watch?v=VZRVt9r4oSM

      Testing for drugs and toxins can be performed on a variety of specimens. Choosing the most appropriate one depends on the purpose of the analysis.

      Blood

      Blood is the specimen of choice for assessing the amount of active drug in a patient. This information is required in a number of situations, such as:

       monitoring the concentration of a prescribed drug to ensure therapeutic levels are present (eg, carbamazepine in a patient with epilepsy)

       measuring the amount of a potentially toxic drug to guide therapy and assess prognosis (eg, acetaminophen in a patient who took an overdose)

       identifying a cause for altered mental status (eg, ethanol in a comatose patient).

      In most cases, drugs are measured in serum. Whole blood is required for certain analyses, because the drug or toxin of interest accumulates within red blood cells.

      Collecting blood is an invasive procedure – inserting a needle through skin into a vein – and it causes anxiety and discomfort to some patients. Experienced phlebotomists can draw blood with little or no associated pain, and they


Скачать книгу